Sell RIM!: Against ...
Cambrex Corporation (CBM: NYSE)
$7.25 0.17 | 2.40%
06/04/12 - 04:01 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 255.65M | 226.99M | 234.55M | 249.23M |
| Cost of Sales | 158.45M | 138.30M | 143.77M | 154.43M |
| Gross Operating Profit | 97.20M | 88.69M | 90.78M | 94.80M |
| Selling, General, and Administrative Expenses | 39.23M | 34.02M | 35.71M | 42.04M |
| Research & Development | 11.04M | 10.30M | 7.93M | 7.59M |
| Operating Income before D & A (EBITDA) | 46.94M | 44.36M | 47.14M | 45.17M |
| Depreciation & Amortization | 23.12M | 21.83M | 20.50M | 21.06M |
| Interest Income | 0.00 | 0.00 | 234.00K | 802.00K |
| Other Income - Net | 111.00K | -596.00K | 641.00K | -754.00K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | 22.31M | 19.36M | 27.51M | 19.47M |
| Interest Expense | 2.37M | 4.39M | 4.87M | 4.47M |
| Pre-Tax Income | 19.94M | 14.97M | 22.64M | 15.00M |
| Income Taxes | 6.20M | 5.66M | 12.25M | 7.07M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | 13.74M | 9.31M | 10.39M | 7.93M |
| Net Income From Discontinued Operations | -2.77M | 338.00K | 0.00 | 0.00 |
| Net Income From Total Operations | 10.97M | 9.65M | 10.39M | 7.93M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | 10.97M | 9.65M | 10.39M | 7.93M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
13.74M | 11.60M | 10.39M | 12.62M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 13.74M | 9.31M | 10.39M | 7.93M |
| Basic EPS from Continuing Ops. | 0.46 | 0.32 | 0.36 | 0.27 |
| Basic EPS from Discontinued Ops. | -0.09 | 0.01 | 0.00 | 0.00 |
| Basic EPS from Total Operations | 0.37 | 0.33 | 0.36 | 0.27 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | 0.37 | 0.33 | 0.36 | 0.27 |
| Basic Normalized Net Income/Share | 0.46 | 0.40 | 0.36 | 0.43 |
| EPS fr Continuing Ops. | 0.46 | 0.32 | 0.36 | 0.27 |
| EPS fr Discontinued Ops | -0.09 | 0.01 | 0.00 | 0.00 |
| EPS fr Total Ops. | 0.37 | 0.33 | 0.36 | 0.27 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | 0.37 | 0.33 | 0.36 | 0.27 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0.46 | 0.40 | 0.36 | 0.43 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with CBM
- Portfolio NameUser Type
- ContributorStocks At New 52-Week Highs...
- UserSUPRATRADE HOT STOCKS (BUY ...
- UserPART 2 JPMorgan 28th Annual...
- UserPART 3 JPMorgan 27th Annual...
- UserRocket Stocks For The Week ...
- UserValue Seeker
- UserPART 3 JPMorgan 26th Annual...
- Userjmj2321 Portfolio 1
- Userxfirst portfoliox
- UserStian Trellevik Biotech bet
Latest CBM Headlines from TheStreet
- Cambrex Stock Gaps Up On Today's Open (CBM) 05.04.12 | 09:05 am
- Cambrex Corporation Stock Upgraded (CBM) 02.08.12 | 06:02 am
- NYSE Stocks Posting Largest Percentage Decreases 02.07.12 | 06:02 pm
- NYSE Stocks Posting Largest Percentage Decreases 02.07.12 | 01:02 pm
- Cambrex Stock Gaps Down On Today's Open (CBM) 02.07.12 | 09:02 am
- Cambrex Stock Hits New 52-Week High (CBM) 01.27.12 | 01:01 pm
- NYSE Stocks Posting Largest Percentage Increases 11.07.11 | 06:11 pm
- NYSE Stocks Posting Largest Percentage Increases 11.07.11 | 01:11 pm
- Cambrex Stock Soars (CBM) 08.03.11 | 10:08 am
- Cambrex Stock Soars (CBM) 05.12.11 | 04:05 pm
Press Releases for CBM
- Cambrex To Present At UBS 22nd Annual Global Healthcare Services Conference - PR Newswire 02.06.12 | 03:02 pm
- Cambrex And Tillotts Enter A Development And Commercialization Agreement For Proprietary 5-ASA-Based Technology - PR Newswire 07.06.11 | 08:07 am
- Cambrex Zenara Manufacturing Facility Receives European GMP Approval - PR Newswire 01.18.11 | 09:01 am
- Shawn P. Cavanagh Appointed Chief Operating Officer Of Cambrex - PR Newswire 01.07.11 | 01:01 pm
- Cambrex Zenara Supplies Product For Launch Of Nicorette® In India - PR Newswire 01.06.11 | 03:01 pm
- Cambrex Acquires Stake In Zenara Pharma - PR Newswire 11.02.10 | 04:11 pm
- Cambrex Acquires IEP GmbH - PR Newswire 03.22.10 | 01:03 pm
- Cambrex Reports Fourth Quarter And Full Year 2009 Results - PR Newswire 02.10.10 | 05:02 pm
- Cambrex Presentation At The JPMorgan Healthcare Conference To Be Webcast - PR Newswire 01.05.10 | 08:01 am
Partner Headlines for CBM
- If Europe Gets Worse, Stay Away From These 13 U.S. Stocks - Seeking Alpha 11.11.11 | 04:11 pm
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 11.08.11 | 09:11 am
- 9 Small Caps With Positive Earnings Trends - Seeking Alpha 09.16.11 | 08:09 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.31.11 | 09:08 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 08.23.11 | 09:08 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 08.19.11 | 09:08 am
- Shawn P. Cavanagh Appointed Cambrex COO - Benzinga 01.07.11 | 01:01 pm
- Cambrex Acquires Stake in Zenara Pharma for $20M - Benzinga 11.02.10 | 04:11 pm





